Regional Anesthesia in TKA: Impact on Postoperative Joint Motion and Patient Satisfaction
Evaluation of the Effects of Regional Anesthesia Methods Applied in Total Knee Arthroplasty on Joint Range of Motion in the Postoperative Period and Patient Satisfaction
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a single-center, prospective, randomized controlled trial aiming to evaluate the effects of different regional anesthesia/analgesia techniques on postoperative knee range of motion (ROM) and patient satisfaction following total knee arthroplasty (TKA). Ninety patients undergoing elective TKA under spinal anesthesia will be randomly assigned to one of three groups: 1) spinal anesthesia with epidural catheter, 2) spinal anesthesia followed by adductor canal catheterization, and 3) spinal anesthesia with multimodal intravenous analgesia. The primary outcome is postoperative knee joint ROM measured on postoperative days 1, 2, and 3. Secondary outcomes include patient satisfaction, Oxford Knee Score, postoperative opioid consumption, and VAS scores. The study is conducted at Konya City Hospital and will be completed over a 6-month period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 5, 2025
CompletedFirst Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
August 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2026
CompletedAugust 28, 2025
August 1, 2025
6 months
August 8, 2025
August 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative Knee Range of Motion (ROM)
Knee joint flexion and extension range of motion will be measured using a standard goniometer by a blinded assessor. Measurements will be performed with the patient in a supine position, ensuring standardized positioning for all participants.
Postoperative day 1, day 3, day 7, and day 90 after surgery.
Secondary Outcomes (5)
Total Opioid Consumption
From the end of surgery to 72 hours postoperatively.
Oxford Knee Score (OKS)
Preoperatively (baseline) and postoperative day 90.
Visual Analog Scale (VAS) Pain Score
Postoperative day 1, day 3, and day 7 after surgery.
Incidence of Adverse Events Related to Anesthesia or Analgesia
Intraoperative period and up to 90 days postoperatively.
Patient Satisfaction Score
Postoperative day 3 and day 90 after surgery.
Study Arms (3)
Combined Spinal-Epidural Anesthesia
ACTIVE COMPARATORPostoperative analgesia will be provided via epidural catheter with programmed infusion of bupivacaine .
Adductor Canal Block
ACTIVE COMPARATORUltrasound-guided adductor canal catheter placement and continuous infusion of bupivacaine .
Multimodal Intravenous Analgesia
SHAM COMPARATORContinuous intravenous tramadol infusion with rescue analgesia as required.
Interventions
This single-center, prospective, randomized controlled trial aims to compare the effects of three different postoperative analgesia techniques following spinal anesthesia in patients undergoing total knee arthroplasty (TKA). The study will assess the impact of combined spinal-epidural anesthesia, adductor canal block, and multimodal intravenous analgesia on postoperative knee range of motion (ROM). Secondary outcomes include patient satisfaction, opioid consumption, Oxford Knee Score (OKS), activity levels, and visual analog scale (VAS) pain scores.
Eligibility Criteria
You may qualify if:
- Scheduled for primary total knee arthroplasty
- Age ≥ 18 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Accepting neuraxial anesthesia
You may not qualify if:
- Skin infection at the planned injection site
- Sepsis
- Coagulopathy
- Refusal of neuraxial anesthesia
- Severe hypovolemia
- Demyelinating central nervous system disease
- Age under 18 years
- Illiterate in Turkish
- Non-cooperative patients
- Known allergy or hypersensitivity to bupivacaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yasin Tire
Konya, Meram, 42140, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr. Yasin Tire
Study Record Dates
First Submitted
August 8, 2025
First Posted
August 15, 2025
Study Start
August 5, 2025
Primary Completion
February 12, 2026
Study Completion
February 19, 2026
Last Updated
August 28, 2025
Record last verified: 2025-08